SICKLE CELL AND THALASSAEMIA SCREENING
Screening is the process of identifying people who appear healthy but may be at increased risk of a disease or condition.
Healthcare professionals will offer information, further tests and appropriate treatment to reduce their risk or any complications arising from the disease or condition.
In March 2015 the Sickle Cell and Thalassaemia Screening Programme Advisory Group set up a sub group to focus on the timeliness of antenatal screening and prenatal diagnosis. The subgroup included parents of children with sickle cell disease and thalassaemia, representatives from UKTS and the Sickle Cell Society and representatives from midwifery, obstetric and genetic counselling professional organisations.
We encourage you to share your story with the Infected Blood Inquiry. It is essential that those infected have their voices heard in this Inquiry.
The UKTS is a member of the Prescription Charges Coalition, an alliance of charities campaigning to abolish prescription charges for all people living with long term medical conditions.
Every day thousands of people’s lives are saved or improved thanks to the generosity of donors like you.
The Hepatitis C Coalition is a group of leading clinicians, patient organisations and other interested parties committed to the reduction of morbidity and mortality resulting from hepatitis C, and the eventual elimination of the virus.
Some 214,000 people in the UK are thought to be living with chronic HCV. Many of these do not know that they have the virus and at present only 4% of those chronically infected receive treatment each year – an unacceptably low number.
Yet with the right diagnosis and treatment, HCV is curable, thanks to new therapies that are now available. Research from the London Joint Working Group on Substance Use & Hepatitis C (LJWG) found it was cheaper to treat chronic hepatitis C virus (CHCV) than to allow the disease to progress, and that treating just 10% of those people with HCV could save £200 million in London alone.
